Key result
VAD placement is linked to reversal of cardiomyocyte senescence and microvascular remodeling in pediatric HLHS.
Observational (n=21)
Cardiomyocyte senescence and a specific senescent microvascular niche drive HLHS-associated heart failure and can be reversed by mechanical unloading, suggesting senolytics as a potential therapeutic strategy.
Background: Hypoplastic left heart syndrome (HLHS) is a severe congenital heart disease (CHD) characterized by an underdeveloped left ventricle. Survival depends on staged palliative surgeries that reconfigure circulation, forcing the single right ventricle (RV) to support systemic circulation. However, the RV experiences excessive volume overload, pressure overload and hypoxia, leading to progressive heart failure. The molecular mechanisms underlying HLHS-associated heart failure remain unclear. Hypothesis: We hypothesize that cardiac cells undergo senescence. Multiple types of senescent cells orchestrate a tissue microenvironment that contributes to heart failure. Methods: We analyzed RV tissue from 21 pediatric HLHS patients across heart failure stages using single-nucleus RNA sequencing and spatial transcriptomics. Longitudinal samples from the same patient were compared before and after ventricular assist device (VAD) placement to assess the effects of mechanical unloading. Additionally, we used patient-derived induced pluripotent stem cells (iPSCs) to investigate the transmissibility of senescence from HLHS cardiomyocytes to healthy donor cardiomyocytes. Results: HLHS hearts exhibited widespread CM senescence at birth, preceding heart failure. Spatial transcriptomics identified a unique senescent microvascular niche comprising hypoxic endothelial cells and pericytes, mechanically stressed senescent fibroblasts, and macrophages with impaired efferocytosis. This microenvironment was specific to HLHS and absent in pediatric failing hearts with dilated or hypertrophic cardiomyopathy. VAD placement alleviated CM senescence and largely reversed the senescent niche. iPSC-derived cardiomyocyte experiments further demonstrated that senescence is transmissible from HLHS cardiomyocytes to healthy donor cells, suggesting a mechanism for disease propagation. Conclusions: Cardiomyocyte senescence and a senescent microvascular niche are key features of HLHS-associated heart failure. The reversal of senescence following mechanical unloading highlights senolytic therapies as a potential treatment strategy.
No takes yet. Share an insight, caveat, or question.
Li et al. (2025) conducted an observational in Hypoplastic left heart syndrome (HLHS) (n=21). Ventricular assist device (VAD) placement vs. Before VAD placement was evaluated on Cardiomyocyte senescence and senescent microvascular niche. Ventricular assist device placement alleviated cardiomyocyte senescence and largely reversed the senescent microvascular niche in pediatric patients with hypoplastic left heart syndrome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from Circulation Research